(Q37896654)

25 August 2017

1 reference

title

PPARs and their effects on the cardiovascular system (English)

1 reference

25 August 2017

1 reference

Adebayo Oyekan

1

1 reference

25 August 2017

publication date

1 July 2011

1 reference

Clinical and Experimental Hypertension

25 August 2017

published in

1 reference

25 August 2017

volume

33

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

287-293

1 reference

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptor alpha target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

PPARalpha governs glycerol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Beta-cell rejuvenation with thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The many faces of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Signalling role of adipose tissue: adipokines and inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

C-reactive protein is elevated in obese patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

PPARgamma and atherosclerosis: effects on cell growth and movement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Endothelium, inflammation, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

The anti-apoptotic role of PPARβ contributes to efficient skin wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2010.531845

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.3109/10641963.2010.531845

15 July 2023

Identifiers

DOI

1 reference

25 August 2017

1 reference